These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22351731)

  • 1. ACP Journal Club. Review: VTE prophylaxis in nonsurgical inpatients reduces PE but not death, and increases major bleeding.
    Freeman AL; Pendleton RC
    Ann Intern Med; 2012 Feb; 156(4):JC2-05. PubMed ID: 22351731
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club: rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE.
    Witt DM
    Ann Intern Med; 2012 Aug; 157(4):JC2-6. PubMed ID: 22910960
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club: apixaban reduced recurrence and did not increase major bleeding in previously treated VTE.
    Moll S
    Ann Intern Med; 2013 Apr; 158(8):JC2. PubMed ID: 23588767
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP journal club. Apixaban reduced VTE and did not increase major bleeding compared with enoxaparin in hip replacement.
    Douketis J
    Ann Intern Med; 2011 May; 154(10):JC5-07, JC5-06. PubMed ID: 21576525
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club: review: fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg.
    Stevens SM
    Ann Intern Med; 2012 Aug; 157(4):JC2-4. PubMed ID: 22910958
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Extended-duration enoxaparin reduced VTE but increased major bleeding in patients with acute medical illness.
    Gallus A
    Ann Intern Med; 2010 Nov; 153(10):JC5-8. PubMed ID: 21079215
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Enoxaparin plus idrabiotaparinux was noninferior to enoxaparin plus warfarin for recurrent VTE in acute PE.
    Dentali F
    Ann Intern Med; 2012 May; 156(10):JC5-4. PubMed ID: 22586022
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Outpatient treatment was noninferior to inpatient treatment for preventing recurrent VTE in low-risk patients with acute PE.
    Bates SM; Guyatt GH
    Ann Intern Med; 2011 Oct; 155(8):JC4-2. PubMed ID: 22007061
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Review: Aspirin reduces vascular events but increases bleeding in primary and secondary prevention.
    Mukherjee D
    Ann Intern Med; 2009 Sep; 151(6):JC3-4, JC3-5. PubMed ID: 19755350
    [No Abstract]   [Full Text] [Related]  

  • 10. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
    Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACP Journal Club. Review: Tight glucose control reduces septicemia, but not death, and increases hypoglycemia in critically ill adults.
    Dodek P
    Ann Intern Med; 2009 Jan; 150(2):JC1-5. PubMed ID: 19172710
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
    J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prevention in acutely ill nonsurgical patients.
    Brophy DF; Dougherty JA; Garrelts JC; Parish RC; Rivey MP; Stumpf JL; Taylor CT; Mathis AS
    Ann Pharmacother; 2005; 39(7-8):1318-24. PubMed ID: 15941823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACP Journal Club. Review: Aspirin does not reduce CHD or cancer mortality but increases bleeding.
    Rembold CM
    Ann Intern Med; 2012 Jun; 156(12):JC6-3. PubMed ID: 22711104
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients.
    Panju M; Raso D; Patel A; Panju A; Ginsberg J
    J R Coll Physicians Edinb; 2011 Dec; 41(4):304-8. PubMed ID: 22184567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACP Journal Club. Fondaparinux reduced a composite of VTE complications or death in superficial leg-vein thrombosis.
    Ageno W
    Ann Intern Med; 2011 Feb; 154(4):JC2-3. PubMed ID: 21320930
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Weekly INR self-testing did not reduce stroke, major bleeding, or death more than monthly clinic testing.
    Witt DM
    Ann Intern Med; 2011 Jan; 154(2):JC1-4, JC1-5. PubMed ID: 21242358
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Aspirin reduced recurrence of venous thromboembolism (VTE) after a first-ever, unprovoked VTE.
    Rabinowitz I
    Ann Intern Med; 2012 Oct; 157(8):JC4-3. PubMed ID: 23070505
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. Review: daily aspirin reduces long-term risk for death due to some types of cancer.
    Singh S
    Ann Intern Med; 2011 Mar; 154(6):JC3-2. PubMed ID: 21403065
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Review: Dabigatran increases MI and reduces mortality compared with warfarin, enoxaparin, or placebo.
    Cairns J
    Ann Intern Med; 2012 Jun; 156(12):JC6-11. PubMed ID: 22711112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.